Oyster Point Pharma, Inc. (OYST) has 13 open-market insider trades by 10 insiders since 2019. The most active filer is Clare Ozawa, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Clare Ozawa | Dir10% Owner | — | 2 | $17.1M | 2023-01-03 |
| Forest Baskett | 10% Owner | — | 1 | $15.0M | 2019-11-04 |
| InvOpps GP IV, L.L.C. | Dir10% Owner | — | 1 | $12.0M | 2023-01-03 |
| William J. Link Ph.D. | Dir | — | 2 | $8.5M | 2022-01-05 |
| InvOpps IV US, L.P. | Dir10% Owner | — | 1 | $5.0M | 2020-05-19 |
| Vida Ventures, LLC | 10% Owner | — | 1 | $3.0M | 2019-11-04 |
| Henry R. Kravis | 10% Owner | — | 1 | $2.5M | 2019-11-04 |
| John Snisarenko | CCO | — | 2 | $152K | 2022-01-09 |
| Daniel Lochner | CFO | — | 1 | $101K | 2023-01-03 |
| Jeffrey Nau | Pres | — | 1 | $16K | 2023-01-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | 10% | Sell | $8.2M | 2021-10-18 |
| William J. Link Ph.D. | Director | Sell | $16.3M | 2021-10-18 |
| John Snisarenko | CCO | Buy | $104K | 2020-08-10 |
| InvOpps IV US, L.P. | Director & 10% Owner | Buy | $5.0M | 2020-05-19 |
| William J. Link Ph.D. | Director & 10% Owner | Buy | $440K | 2019-11-04 |
| InvOpps GP IV, L.L.C. | Director & 10% Owner | Buy | $12.0M |
Companies that share insiders with OYST, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-11-04 |
| John Snisarenko | Chief Commercial Officer | Buy | $48K | 2019-11-04 |
| Clare Ozawa | Director | Buy | $9.0M | 2019-11-04 |
| Jeffrey Nau | President | Buy | $16K | 2019-11-04 |
| Vida Ventures, LLC | 10% Owner | Buy | $3.0M | 2019-11-04 |
| Forest Baskett | 10% Owner | Buy | $15.0M | 2019-11-04 |
| Daniel Lochner | CFO | Buy | $101K | 2019-11-04 |
| Henry R. Kravis | 10% Owner | Buy | $2.5M | 2019-11-04 |